Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

54.42
-0.5200-0.95%
Post-market: 54.04-0.3800-0.70%19:33 EDT
Volume:1.56M
Turnover:85.70M
Market Cap:5.19B
PE:-12.47
High:56.66
Open:55.74
Low:54.29
Close:54.94
52wk High:63.95
52wk Low:26.74
Shares:95.43M
Float Shares:89.89M
Volume Ratio:1.03
T/O Rate:1.73%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3646
EPS(LYR):-4.3646
ROE:-51.76%
ROA:-32.58%
PB:8.93
PE(LYR):-12.47

Loading ...

Jan 17, 2025

Major Issues Report

Form 8-K - Current report
Dec 18, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 19, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]